SMSPHARMABSESMS Pharmaceuticals Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 22 Aug, 2025 · 10:45 IST

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.4%Reaction day
₹240.40
prior close
₹237.77
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-0.8% vs market
Pharmaceuticals peers, median of 151sector-0.1%-1.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.2
15m
+0.2
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.4-0.6-0.8-0.1-1.3
Next day
-2.6-0.7-1.9-0.5-2.1
2d
-3.9-2.4-1.4-1.6-2.3
3d
-7.4-3.1-4.3-2.7-4.8
4d
-1.6-3.3+1.7-2.9+1.3
5d
-0.6-2.0+1.5-1.6+1.0
1w
-2.3-0.2-2.1-0.9-1.4
15d
+21.1+0.7+20.3-0.4+21.4
1m
+17.7+1.3+16.4-0.0+17.7
2m
+17.0-0.2+17.1-2.8+19.8
3m
+12.7-3.6+16.4-6.2+18.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Hima Bindu Potluri has disclosed that 30,00,000 (30 lakh) equity shares were released from a Non-Disposal Undertaking (NDU) on 19 August 2025, and the same number of shares were pledged on 20 August 2025. The net effect is essentially neutral — one form of encumbrance (NDU) has been swapped for another (pledge). The filing is made under Regulation 29 and 31 of the SEBI SAST Regulations, 2011. The Annexure II on reasons for encumbrance appears incomplete, with key debt-related details left blank in the document.

Likely market impact

The overall encumbrance level on promoter shares remains unchanged, so there is no immediate dilution risk or change in promoter control. However, the shift from NDU to pledge suggests the promoter may be raising funds or providing collateral, which retail investors should monitor for any future pledge invocation or invocation-related disclosures.